Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells From Patients With Idiopathic Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells From Patients With Idiopathic Pulmonary Arterial Hypertension

Published:2010-01 Issue:1 Volume:55 Page:39-48
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Ikeda Tetsuya,Nakamura Kazufumi,Akagi Satoshi,Kusano Kengo Fukushima,Matsubara Hiromi,Fujio Hideki,Ogawa Aiko,Miura Aya,Miura Daiji,Oto Takahiro,Yamanaka Ryutaro,Otsuka Fumio,Date Hiroshi,Ohe Tohru,Ito Hiroshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference34 articles.

1. Primary pulmonary hypertension.;Rubin;N Engl J Med,1997

2. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.;Pietra;Circulation,1989

3. Reversal of experimental pulmonary hypertension by PDGF inhibition.;Schermuly;J Clin Invest,2005

4. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.;Rich;N Engl J Med,1992

5. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.;Sitbon;J Am Coll Cardiol,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension;Frontiers in Genetics;2023-09-04

2. Statins and the Lung: Hope or Hype?;The Indian Journal of Chest Diseases and Allied Sciences;2022-06-10

3. An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension;Molecules;2022-05-29

4. COMBINATION TREATMENT WITH STATINS AND BEZAFIBRATE INDUCES MYOTOXICITY VIA INHIBITION OF GERANYLGERANYL PYROPHOSPHATE BIOSYNTHESIS AND RHO ACTIVATION IN L6 MYOBLASTS AND MYOTUBE CELLS;J PHYSIOL PHARMACOL;2022

5. Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study;Scientific Reports;2020-02-20